HDAC3 and heart failure: Accordingly, blockade of either CD47, HDAC3 or CaMKII has beneficial cardiac effects by reducing hypertrophy and softening heart failure [155] thereby underlining a value of the TSP1/CD47 pathway in the pathogenesis of heart failure.